Elutia (ELUT) Stock Price, Quote, News & History | Benzinga

Elutia Inc (ELUT) Stock Price, Quote, News & History

ELUTNASDAQ

Trade with Public

Trade with Public

$0.9550

0.00410.43%

At close: Aug 24, 5:00 PM EST

$0.9359

-0.0191-2%

After Hours: 7:07 PM EST

M&A: Elutia (ELUT) sold assets to Cellution Biologics Inc. on Tuesday, August 18, 2026 for $11M

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$0.95

Close

$0.96

Volume / Avg.

8.10K / 84.17K

Day Range

$0.90 - $0.96

52 Wk Range

0.50 - 2.50

Market Cap

$41.45M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

0.1%

Days to Cover

1

Recent Elutia Inc News

Elutia Sheds Legacy Business to Chase $1.5 Billion Market Opportunity

Elutia (NASDAQ:ELUT) sells SimpliDerm to Cellution Biologics for up to $11M to boost its balance sheet ahead of the NXT-41x launch.

Vandana Singh

Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.

Lisa Levin

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.

Lisa Levin

Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket

Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to also serve as the company’s Chief Privacy Officer.

Lisa Levin

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-43.99M

Investing Cash Flow (TTM)

78.83M

Financing Cash Flow (TTM)

-23.44M

Free Cash Flow (TTM)

-46.03M

Capital Expenditure (TTM)

-2.03M

Net Change in Cash (TTM)

11.40M

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$26.13M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.52

PB Ratio (TTM)

2.65

Earnings Yield % (TTM)

-66.99%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.36

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$19.90M

Debt to Equity

0.28

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.95

Close

$0.96

Volume / Avg.

8.10K / 84.17K

Day Range

$0.90 - $0.96

52 Wk Range

0.50 - 2.50

Market Cap

$41.45M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

53

Short Interest

0.1%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include C...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Elutia (ELUT) stock?

A

You can purchase shares of Elutia (NASDAQ:ELUT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Elutia (ELUT) competitors?

A

Other companies in Elutia’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Elutia (ELUT) stock?

A

Elutia has a consensus price target of $7.00.

Q

What is the current price for Elutia (ELUT)?

A

The stock price for Elutia (NASDAQ: ELUT) is $0.9359 last updated August 24, 2026 at 7:07 PM EDT.

Q

Does Elutia (ELUT) pay a dividend?

A

There are no upcoming dividends for Elutia.

Q

When is Elutia (NASDAQ:ELUT) reporting earnings?

A

Elutia does not have any upcoming earnings scheduled.

Q

Is Elutia (ELUT) going to split?

A

There is no upcoming split for Elutia.

Q

What sector and industry does Elutia (ELUT) operate in?

A

Elutia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.